O

Oncolytics Biotech
ONC

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
CA$68.41M
EV
CA$53.54M
Shares Outstanding
86.60M
Beta
1.55

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
CA$4.69
P/E 2025E
-
P/Revenue 2025E
61.02x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Oncolytics Biotech Inc.

gainify

O

Oncolytics Biotech Inc.

ONC

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in ...

Sector

Healthcare

Industry

Biotechnology

CEO

Pisano, Wayne

Employees

28

IPO Date

2000-06-01

Headquarters

322 11th Avenue SW, Suite 804, Calgary, Alberta, T2R 0C5, Canada

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved